EuroIntervention

Scope & Guideline

Exploring the Frontiers of Cardiovascular Medicine

Introduction

Immerse yourself in the scholarly insights of EuroIntervention with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1774-024x
PublisherEUROPA EDITION
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 2008 to 2024
AbbreviationEUROINTERVENTION / EuroIntervention
Frequency-
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address19 ALLEES JEAN JAURES B P 61508, TOULOUSE CEDEX 6 31015, FRANCE

Aims and Scopes

EuroIntervention focuses on advancing the field of interventional cardiovascular medicine, particularly through innovative techniques and devices for managing coronary and valvular heart diseases.
  1. Transcatheter Aortic Valve Implantation (TAVI):
    The journal frequently publishes studies on TAVI, exploring its effectiveness, complications, and advancements in valve technology.
  2. Percutaneous Coronary Intervention (PCI):
    Research on PCI techniques, including stenting, drug-coated balloons, and the management of complications, is a core focus area.
  3. Innovative Devices and Techniques:
    The journal highlights novel devices and methodologies, such as robotic assistance in procedures, and new stent technologies.
  4. Clinical Outcomes and Predictive Models:
    Studies assessing the long-term outcomes of various interventions and the development of predictive models for patient outcomes are prevalent.
  5. Antithrombotic Therapy:
    Exploration of antithrombotic strategies, including dual antiplatelet therapy (DAPT) and its implications in different patient populations.
  6. Valvular Heart Disease Interventions:
    Research on interventions for mitral and tricuspid valve diseases, including edge-to-edge repair techniques, is also prominent.
EuroIntervention has identified several emerging research themes that reflect the current trends in interventional cardiovascular medicine, driven by technological advancements and evolving clinical practices.
  1. Hybrid Approaches to Treatment:
    There is a growing interest in hybrid therapies that combine surgical and percutaneous methods, particularly in complex cases involving multi-valvular disease.
  2. Use of Artificial Intelligence (AI):
    AI applications in predicting outcomes, optimizing procedures, and enhancing imaging analysis are increasingly featured in recent publications.
  3. Patient-Centric Approaches:
    Research focusing on patient-reported outcomes, shared decision-making, and personalized treatment plans is on the rise, emphasizing the importance of patient preferences in clinical practice.
  4. Long-term Durability of Devices:
    Studies investigating the long-term performance and outcomes of newer devices, especially bioresorbable scaffolds and advanced stenting platforms, are gaining traction.
  5. Management of Non-Obstructive Coronary Artery Disease (MINOCA):
    An increasing number of studies are focusing on the diagnosis and management strategies for MINOCA, reflecting a shift towards understanding this complex condition.

Declining or Waning

While EuroIntervention continues to thrive in many areas, certain themes have seen a decline in prominence, reflecting shifts in clinical practice and research focus.
  1. Traditional Surgical Techniques:
    There has been a noticeable decrease in publications focused solely on traditional surgical interventions, as the field shifts towards less invasive, transcatheter approaches.
  2. Conventional Imaging Techniques:
    Research dedicated to older imaging modalities is waning in favor of advanced intravascular imaging techniques like optical coherence tomography (OCT) and intravascular ultrasound (IVUS).
  3. General Antithrombotic Guidelines:
    Specific guidelines that do not account for individual patient risk profiles are becoming less common, as personalized medicine approaches gain traction.
  4. Single Antiplatelet Therapy:
    There is a declining emphasis on the use of single antiplatelet therapy, especially in high-risk populations, with more focus on tailored DAPT strategies.
  5. Pharmacological Approaches in Isolation:
    Research that does not integrate procedural techniques with pharmacological management is becoming less frequent, as a more holistic approach is favored.

Similar Journals

JOURNAL OF CARDIAC SURGERY

Exploring the forefront of cardiovascular medicine.
Publisher: WILEY-HINDAWIISSN: 0886-0440Frequency: 1 issue/year

The Journal of Cardiac Surgery, published by Wiley-Hindawi, stands as a pivotal resource in the fields of cardiology, cardiovascular medicine, and surgery, addressing critical developments and innovations in surgical techniques and patient management. Established in 1986, this esteemed journal has cultivated a reputation for nurturing high-quality research, as evidenced by its 2023 Scopus rankings, placing it in the top half for both Medicine: Surgery and Medicine: Cardiology and Cardiovascular Medicine. With an impact factor indicative of its influence in the scientific community, the journal is an essential platform for researchers, medical professionals, and students eager to stay abreast of advancements in cardiac surgery. Readers can access a range of original articles, reviews, and case studies that contribute significantly to our understanding of surgical practices and outcomes. As it converges towards its 2024 milestone, the journal continues to emphasize the importance of innovation in cardiac care, underscoring its commitment to improving patient outcomes worldwide.

ACTA CARDIOLOGICA

Transforming challenges into solutions in cardiology.
Publisher: TAYLOR & FRANCIS LTDISSN: 0001-5385Frequency: 6 issues/year

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

Netherlands Heart Journal

Fostering Innovation in Heart Health Through Scholarly Discourse
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

Journal fur Kardiologie

Illuminating the Path of Cardiovascular Innovation.
Publisher: KRAUSE & PACHERNEGG GMBHISSN: 1024-0098Frequency: 12 issues/year

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

Revista Portuguesa de Cardiologia

Exploring innovative solutions in cardiology since 1970.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

Korean Circulation Journal

Advancing Cardiovascular Knowledge, One Study at a Time.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Heart International

Pioneering discoveries in the realm of cardiovascular science.
Publisher: TOUCH MEDICAL MEDIA LTDISSN: 2036-2579Frequency: 2 issues/year

Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.

Seminars in Thoracic and Cardiovascular Surgery

Advancing the Frontiers of Cardiovascular and Thoracic Surgery
Publisher: ELSEVIER INCISSN: 1043-0679Frequency: 4 issues/year

Seminars in Thoracic and Cardiovascular Surgery, published by Elsevier Inc, is a prestigious journal that focuses on advancing the fields of thoracic and cardiovascular surgery, cardiology, and pulmonary medicine. With a strong impact factor and an impressive reputation indicated by its 2023 rankings as Q2 in Cardiology and Cardiovascular Medicine, and Q1 in both Medicine (miscellaneous) and Surgery, the journal occupies a critical space in the academic landscape. Established in 1989, it has become a vital resource for researchers, clinicians, and students alike, fostering innovation through comprehensive reviews and cutting-edge studies. Although it does not offer open access, its robust editorial standards ensure that published articles contribute significantly to the ongoing discourse in surgical techniques and procedural advancements. Researchers and practitioners are encouraged to explore its rich compendium of peer-reviewed content that informs clinical practices and guides future investigations in the dynamic and evolving realm of thoracic and cardiovascular health.

Cardiovascular Revascularization Medicine

Empowering Innovations in Cardiovascular Care
Publisher: ELSEVIER INCISSN: 1553-8389Frequency: 12 issues/year

Cardiovascular Revascularization Medicine, published by Elsevier Inc, serves as a pivotal platform for research and clinical advancements in the field of cardiology and cardiovascular medicine. With an ISSN of 1553-8389 and an E-ISSN of 1878-0938, this journal has been a key resource since its inception in 2005, converging to highlight innovative approaches for cardiovascular interventions and revascularization techniques through 2024. Although it currently holds a Q3 ranking in both cardiology and general medicine categories as per the 2023 metrics, it continues to empower researchers and healthcare professionals by publishing peer-reviewed articles that bridge the gap between experimental and clinical medicine. With comprehensive coverage of emergent therapies and procedural advancements, Cardiovascular Revascularization Medicine is essential for anyone aiming to stay abreast of the evolving landscape of cardiovascular treatment. Researchers, professionals, and students alike will find invaluable insights and evidence-based research that can impact patient outcomes positively.

AMERICAN JOURNAL OF CARDIOLOGY

Pioneering Research in Cardiology and Cardiovascular Medicine
Publisher: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INCISSN: 0002-9149Frequency: 24 issues/year

The American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.